Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

188
Delayed Quote. Delayed BATS EUROPE - 12/17 04:55:30 pm
260.0000 DKK   +0.04%
3d ago Novo Nordisk A/S - Share repurchase programme
3d ago SILENCE THERAPE : Appoints Karlsson Head Of Research & Development
6d ago NOVO NORDISK A/ : Brings One-Stop Diabetes Care to African Cities
 SummaryChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Copenhagen Stock Exchange
12/11/2014 12/12/2014 12/15/2014 12/16/2014 12/17/2014 Date
275.8 269.1 263.5 260.2 259.9 Last
2163914 2091901 2687930 3792044 2874525 Volume
-0.14% -2.43% -2.08% -1.25% -0.12% Change
Company
Novo Nordisk AS is engaged in the development, manufacture, and marketing of pharmaceutical products.It operates through the Diabetes Care and Biopharmaceuticals segments.The Diabetes Care segment deals with the research, development, manufacture, and marketing of products within the areas of... 
Sector
Pharmaceuticals
Calendar
01/30Earnings Release
More about the company
Surperformance© ratings of Novo Nordisk A/S
Trading Rating : Investor Rating :
More Ratings
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Full-screen chart
Financials ( DKK)
Sales 2014 88 515 M
EBIT 2014 34 025 M
Net income 2014 26 372 M
Finance 2014 10 570 M
Yield 2014 1,82%
Sales 2015 97 937 M
EBIT 2015 38 834 M
Net income 2015 29 650 M
Finance 2015 11 596 M
Yield 2015 2,09%
PER 2014 26,03
PER 2015 22,58
EV / Sales 2014 6,09x
EV / Sales 2015 5,49x
Capitalization 549 689 M
More Financials
Latest news on NOVO NORDISK A/S
1d ago NOVO NORDISK A/S : Recent Findings in Gestational Diabetes Described by Research..
1d ago NOVO NORDISK A/S : Launches Community Health Collaborative™ Aimed At Impro..
1d ago NOVO NORDISK A/S : and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship..
1d ago NOVO NORDISK A/S : Enters Into Agreement with Chip Ganassi Racing
3d ago Novo Nordisk A/S - Share repurchase programme
3d ago SILENCE THERAPEUTICS : Appoints Karlsson Head Of Research & Development
6d ago NOVO NORDISK A/S : Brings One-Stop Diabetes Care to African Cities
7d ago NOVO NORDISK A/S : Places R&D Under the Microscope
More news
Sector news
1d ago TAKEDA PHARMACEUTICAL : Announces Appointment of Andrew Plump, M.D., Ph.D., as C..
1d ago AMGEN : Announces 30 Percent Increase In 2015 First Quarter Dividend
1d ago ZOETIS : Declares First Quarter 2015 Dividend; Board Approves 15% Payment Increa..
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF